This HTML5 document contains 213 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1038/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34276618
rdf:type
wikibase:Item
schema:description
artigo científico 2012年论文 vědecký článek наукова стаття, опублікована в травні 2012 επιστημονικό άρθρο مقالة علمية 2012年論文 2012 թվականի մայիսին հրատարակված գիտական հոդված artikull shkencor 2012年論文 scienca artikolo מאמר מדעי 2012年論文 wetenschappelijk artikel article científic bài báo khoa học سائنسی مضمون 2012年论文 article scientifique (publié 2012) teaduslik artikkel artigo científico (publicado na 2012) mokslinis straipsnis научна статия article scientific мақолаи илмӣ 2012年论文 სამეცნიერო სტატია tudományos cikk ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年论文 artykuł naukowy научни чланак 2012年の論文 2012 թուականի Մայիսին հրատարակուած գիտական յօդուած scientific article 2012년 논문 vedecký článok บทความทางวิทยาศาสตร์ artículo científico publicado en 2012 مقالهٔ علمی bilimsel makale 2012年论文 articolo scientifico 2012年論文 artikulong pang-agham мақолаи илмӣ naučni članak wissenschaftlicher Artikel videnskabelig artikel (udgivet 2012) vitenskapelig artikkel vetenskaplig artikel научни чланак 2012年論文 tieteellinen artikkeli 2012年论文 artigo científico (publicado na 2012) artículu científicu espublizáu en 2012 vitskapeleg artikkel articol științific научная статья 2012 nî lūn-bûn
p:P577
wds:Q34276618-3F05494A-E904-4DA9-A94F-245666073F84
wdt:P577
2012-05-23T00:00:00Z
p:P407
wds:Q34276618-17D6BDC0-6D23-4523-90CF-1380EA355D93
wdt:P407
wd:Q1860
p:P2860
wds:Q34276618-D593FC3E-23D0-4B71-A44D-5E59AB244FCE wds:Q34276618-DA0C1B8B-F3D8-484B-A975-EA0986F26D18 wds:Q34276618-E656CD28-DF8D-4CDD-9847-029783A039D1 wds:Q34276618-60D5F9BF-B3C8-439B-B86F-B751EBB5A152 wds:Q34276618-D09618B7-6AC4-4B07-9191-06CE559070E1 wds:Q34276618-D096C585-2CDF-4405-BE67-1C20C7D64F2E wds:Q34276618-701CF7EE-9691-4914-9C64-BAA6F4038292 wds:Q34276618-FE13E0D3-9857-4E9B-BF1B-F9863859D7DE wds:Q34276618-78C3BFDD-A3A8-408C-9E90-DCE0DE9558C5 wds:Q34276618-FE95FBEF-8E88-4963-8D51-E9C1E96BC5D7 wds:Q34276618-55B58370-1310-4189-956F-C0F250D5FAE9 wds:Q34276618-55C84926-08EB-430A-9DC9-3ECA59605866 wds:Q34276618-5D574950-7D20-4D7E-B520-48A303711B43 wds:Q34276618-EA8C1B05-AAFC-405B-9943-7026301C2CD6 wds:Q34276618-902160C3-4292-41C9-8265-6FCA764C3D2B wds:Q34276618-EC636273-A474-431B-B091-BE2F7982B75C wds:Q34276618-A60BDA9A-32AB-448C-8D92-8F11C1D8E260 wds:Q34276618-7CEBBCEA-3A52-45AE-8710-E271973E8CBF wds:Q34276618-845FAE89-B1DD-4864-8950-583E497C9D4F wds:Q34276618-B93D256D-52A6-481C-BA6A-486310A66189 wds:Q34276618-AC7E271B-591C-4C42-B471-02E8E4AEB732 wds:Q34276618-B1D7E2EB-B4FD-43A3-9E62-D561523FA6F8 wds:Q34276618-CA9CD6B0-4DB7-41D8-91E3-895EE8502BAD wds:Q34276618-BC270C1A-DEC6-4732-9CBD-85A16C835BFE wds:Q34276618-BE74E32F-2330-489A-97A8-4FDFA8A35AEE wds:Q34276618-C26585D4-4D24-4EEA-8083-192C9651942A wds:Q34276618-0EC64FE6-B529-4B31-B0FE-CDDA9A162ACF wds:Q34276618-0EFAADBE-6F95-48C9-BD68-E46C90238D3A wds:Q34276618-0F0714F1-F726-40FC-B6A1-6AF2B74F0031 wds:Q34276618-0FAFFE50-92A4-458B-8BCE-E4C83824EE81 wds:Q34276618-00705C48-BD76-47E8-8E98-405445056C68 wds:Q34276618-0389D0D8-F590-47C7-832A-61A382B6441A wds:Q34276618-046FD1E3-3AC1-4D27-910A-D66BA6A520E7 wds:Q34276618-23FF36C3-44F3-449C-B060-DD4819E4A2B9 wds:Q34276618-2CB7E32B-D1D1-4C66-82C5-915BE5126CDB wds:Q34276618-1E52BAFE-D142-4A14-8B7C-8C8212F04C04 wds:Q34276618-1FB1A3A9-20BB-4619-A4B4-1E4135FE561E wds:Q34276618-1FD24533-9668-44D9-84D6-19587D99B8DE wds:Q34276618-48EC78F7-EBB7-4EAC-B103-613442D8B2F8 wds:Q34276618-3FE38F38-4191-4030-BD67-533815D8FDF5 wds:Q34276618-40B4639B-4777-4077-A449-3AD593830141 wds:Q34276618-45307623-4D98-4410-95DB-519323CC6688
wdt:P2860
wd:Q28269517 wd:Q37627544 wd:Q36438054 wd:Q28257094 wd:Q34550538 wd:Q34207135 wd:Q35697228 wd:Q24632735 wd:Q38512815 wd:Q29619028 wd:Q34187996 wd:Q79296519 wd:Q37172286 wd:Q55041963 wd:Q36158024 wd:Q34372448 wd:Q74283755 wd:Q34530003 wd:Q35622529 wd:Q34612244 wd:Q36558156 wd:Q35634476 wd:Q28214393 wd:Q36515108 wd:Q36986507 wd:Q40561482 wd:Q42757090 wd:Q34644783 wd:Q37473376 wd:Q46560575 wd:Q34166144 wd:Q36303810 wd:Q34334852 wd:Q57825144 wd:Q28209488 wd:Q34561428 wd:Q57825140 wd:Q36186431 wd:Q34626398 wd:Q42661326 wd:Q83935521 wd:Q37794087
p:P2093
wds:Q34276618-479C7307-9CA2-4A7F-B6F6-922E263D7363 wds:Q34276618-50A27203-3C5D-4F94-92C3-7F1A39B61AF4 wds:Q34276618-52B0D168-1103-4730-91AC-F9E0756B4E07 wds:Q34276618-AF369ADE-7525-42DF-833E-66C21749EF49 wds:Q34276618-AC0FC4E3-9019-4D68-B3C9-E7056011116E wds:Q34276618-BB469EB4-74A4-4476-90BC-CCF34B5F7398 wds:Q34276618-BF37903D-860C-49D5-A616-D97583A48822 wds:Q34276618-C303CF25-FFCB-417C-AC40-916F855493BF wds:Q34276618-544ED456-C09E-4BE4-87C1-302D22B2C083 wds:Q34276618-5DD49DB5-CD05-40F1-9D32-2584C0492FC3 wds:Q34276618-E5316DCE-4585-4927-B72D-FA11AFA4E7CB
wdt:P2093
Q Feng W D Maxwell R A Wilke S G Johnson D M Roden Clinical Pharmacogenomics Implementation Consortium (CPIC) R M Krauss R M Cooper-Dehoff T E Klein H L McLeod L Gong
rdfs:label
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
skos:prefLabel
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
schema:name
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
p:P50
wds:Q34276618-C75DA3EF-B1E7-4878-9BDF-3AC85F0E8AC4 wds:Q34276618-930215E4-155C-4D33-A220-61984FD0DC6E wds:Q34276618-EB1BDFA2-07E3-48A2-9149-37383BA25857 wds:Q34276618-CD1DAE2C-09BF-4B03-8F18-49AC0E4E3559
wdt:P50
wd:Q57449573 wd:Q42328966 wd:Q42187542 wd:Q57693303
p:P1476
wds:Q34276618-C3C77E76-0154-4151-9F87-3E9CAB6AC7B3
wdt:P1476
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy
p:P304
wds:Q34276618-B3631E3E-E872-4DB2-8F1F-65258ED1BCAF
wdt:P304
112-117
p:P31
wds:Q34276618-28F5C74D-69A9-4082-801E-FE30A86D1D43
wdt:P31
wd:Q13442814
p:P921
wds:Q34276618-78CE7AD3-137E-4639-8AD3-536194A1756F
wdt:P921
wd:Q1152227
p:P698
wds:Q34276618-CC26DD1F-DE6F-411F-89BC-289D6EA96402
wdtn:P698
n11:22617227
wdt:P698
22617227
p:P1433
wds:Q34276618-ED08799B-576E-42AF-B90A-99402BE36964
wdt:P1433
wd:Q1101529
p:P433
wds:Q34276618-800EAB50-5D81-44B7-A0A8-9242484F4D0D
p:P478
wds:Q34276618-4BC3A924-C33B-445B-9CF0-56986B2E2FF6
wdt:P433
1
wdt:P478
92
p:P356
wds:Q34276618-0A004474-4883-41D1-8518-E2E437B0ACE8
wdtn:P356
n8:CLPT.2012.57
wdt:P356
10.1038/CLPT.2012.57
p:P5875
wds:Q34276618-9313473E-7621-4D19-A9E9-5E8B1D250252
wdt:P5875
225055969
p:P932
wds:Q34276618-B34929F1-D8DD-47A2-BDA2-5936C8EFAF86
wdt:P932
3384438